期刊文献+

恶性血液病血管新生过程中VEGF/R、内皮抑素和基质金属蛋白酶的相互调控探讨 被引量:7

Interregulation of VEGF/R Endostatin and MMP in the Angiogenesis of Hematologic Malignancies —— Review
下载PDF
导出
摘要 恶性血液病血管新生过程中涉及的一些因子,如血管内皮生长因子/受体系统(VEGF/R)、基质金属蛋白酶(MMP)和内皮抑素等(ES)所起的作用及其相互调控机制一直是学术研究的热点。虽然近年来相关研究发展很快,但仍未能形成系统理论。本文就近年来有关VEGF/R系统的正负调控因素,MMP的调控及其与VBGF/R的相互影响,ES的调控及其与VEGF/R和MMP的相互影响等研究进展作一综述。 Some kinds of angiogenic correlation factors, e.g. VEGF/R, MMP, endostatin, are relative to the process of hematologic malignancies. The mechanisms of adjusting themselves and controlling mutually have been hot points of the academic research in last few years. Alhough the rapid progress has been made in studies of this feild, it is still hard to come into a systematic theory now. This article introduces the last progress in the field of positive and negative regulatory factors of VEGF/R system in the angiogenesis of hematologic malignancies, the regulation of MMP and its relation with VEGF/R, the regulation of ES and its relation with VEGF/R and MMP.
作者 张建东 张育
出处 《中国实验血液学杂志》 CAS CSCD 2005年第6期1145-1150,共6页 Journal of Experimental Hematology
关键词 血管新生 VEGF/R MMP 内皮抑素 调控网络 恶性血液病 angiogenesis VEGF/R MMP endostatin interregulatory net hematologic malignancy
  • 相关文献

参考文献48

  • 1Moehler TM, Ho AD, Goldschmidt H, et al. Angiogenesis in hematologic malignancies. Crit Rev Oncol/Hematol, 2003; 45:227-244
  • 2Bellon G, Martiny L, Robinet A. Matrix metalloproteinases and matrikines in angiogenesis. Crit Rev Oncol/Hematol, 2004 ;49:203-220
  • 3Bairey O, Boycov O, Kaganovsky E, et al. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells. Leuk Res, 2004; 28:243-248
  • 4Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med, 2001 ;193:1005-1014
  • 5李晟,陈子兴,王玮,岑建农,付建新,姚利.明胶酶A在急性白血病细胞中的表达及其临床意义[J].中华内科杂志,2003,42(10):684-687. 被引量:15
  • 6Lin LI, Lin DT, Chang CJ, et al. Marrow matrix metalloproteinases (MMP) and tissue inhibitors of MMP in acute leukemia; potential role of MMP-9 as a surrogate marker to monitor leukemic status in patients with acute myelogenous leukemia. Br J Hematol,2002; 117: 835-841
  • 7Verstovsek S, Kantarjian H, Manshouri T, et al. Prognostic significance of celluar vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood, 2002; 99: 2265-2267
  • 8Kay NE, Bone ND, Tschumper RC, et al. B-CLL cells are capable of synthesis and secretion of both pro-and anti-angiogenic molecules. Leukemia, 2002; 16:911-919
  • 9Gora-Tybor J, Blonski JZ, Robak T, et al. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. Mediators Inflamm,2003; 12: 167-171
  • 10杨崇礼.恶性血液病与血管新生[J].白血病.淋巴瘤,2003,12(4):237-243. 被引量:1

二级参考文献85

  • 1刘廷析,刘秀芳,向建平,邹萍,周剑锋,陈燕,喻东姣,李崇渔.急性髓系白血病细胞侵袭能力与粘附分子表达关系探讨[J].中华血液学杂志,1997,18(1):29-31. 被引量:20
  • 2叶任高 沈清瑞.肾脏病诊断和治疗学[M].北京:人民卫生出版社,1994.276-277.
  • 3[1]Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia [J]. Nature, 1989, 339(6219): 58-62.
  • 4[2]Kandel J, Bossy-Wetzel E, Radvanyi F, et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma[J]. Cell, 1991, 66(6): 1095-1021.
  • 5[3]O′Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [J]. Cell, 1994, 79(2): 315-328.
  • 6[4]Good DJ, Polverini PJ, Rastinejad F, et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin [J]. Proc Natl Acad Sci USA,1990, 87(17): 6624-6627.
  • 7[5]Maione TE, Gray GS, Petro J, et al. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides [J]. Science, 1990, 247(4938): 77-82.
  • 8[6]Angiolillo AL, Sgadari C, Taub DD, et al. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo [J]. J Exp Med, 1995, 182(1): 155-159.
  • 9[7]Clapp C, Martial JA, Guzman RC, et al. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis [J]. Endocrinology, 1993, 133(3): 1292-1296.
  • 10[8]O′Reilly MS, Boehm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997, 88(2): 277-285.

共引文献101

同被引文献47

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部